REQUEST A DEMO
Total
USD $0.00
Search more companies

Nefrology Medicronic S.A. (Ecuador)

Main Activities: Offices of Physicians
Full name: Nefrology Medicronic S.A. Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Nefrology Medicronic S.A. is an enterprise based in Ecuador. Its main office is in Quito. It operates in the Offices of Physicians industry. It was incorporated on August 03, 2009. There are currently 21 (2024) people employed by Nefrology Medicronic S.A.. From the latest financial highlights, Nefrology Medicronic S.A. reported a net sales revenue increase of 14.34% in 2024. There was a total growth of 22.91% in Nefrology Medicronic S.A.’s total assets over the same period. The enterprise’s net profit margin increased by 10.35% in 2024.

Headquarters
Antonio de Ulloa N31-144
Quito; Pichincha;

Contact Details: Purchase the Nefrology Medicronic S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Nefrology Medicronic S.A. report to view the information.
Registered Capital:
Purchase the Nefrology Medicronic S.A. report to view the information.
Financial Auditors:
Purchase the Nefrology Medicronic S.A. report to view the information.
Incorporation Date:
August 03, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Nefrology Medicronic S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
14.34%
Total operating revenue
14.16%
Operating profit (EBIT)
57.53%
EBITDA
48.9%
Net Profit (Loss) for the Period
337.13%
Total Assets
22.91%
Total Equity
49.78%
Operating Profit Margin (ROS)
5.94%
Net Profit Margin
10.35%
Return on Equity (ROE)
22.03%
Debt/Equity
-18%
Quick Ratio
0.78%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?